Antiviral activity of Isatis indigotica root-derived clemastanin B against human and avian influenza A and B viruses in vitro

International Journal of Molecular Medicine

Volumn 31, Issue 4, 2013, Pages 867-873

  Yang, Zifeng ^a,b   Wang, Yutao ^b   Zheng, Zhaoguang ^a   Zhao, Suishan ^b   Zhao, Jin ^b   Lin, Qing ^c   Li, Chuyuan ^c   Zhu, Quan ^a   Zhong, Nanshan ^b  

^a MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co Ltd   (China)

Author keywords

Clemastanin B; In vitro; Influenza virus; Virus infection

Indexed keywords

ANTIVIRUS AGENT; CLEMASTANIN B; ISATIS INDIGOTICA EXTRACT; PLANT EXTRACT; RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ANTIVIRAL RESISTANCE; ARTICLE; AVIAN INFLUENZA VIRUS; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; ENDOCYTOSIS; IN VITRO STUDY; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H7N3; INFLUENZA VIRUS A H9N2; INFLUENZA VIRUS B; INFLUENZA VIRUS H6N2; ISATIS; ISATIS INDIGOTICA; NONHUMAN; NUCLEOTIDE SEQUENCE; PLANT ROOT; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADSORPTION; ANALYSIS OF VARIANCE; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CELL NUCLEUS; DOGS; DRUG RESISTANCE, VIRAL; FURANS; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INTRACELLULAR SPACE; ISATIS; MADIN DARBY CANINE KIDNEY CELLS; PLANT EXTRACTS; PLANT ROOTS; VIRAL PLAQUE ASSAY;

EID: 84875242149     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1274     Document Type: Article

References (40)

1. Nicholson KG, Wood JM and Zambon M: Influenza. Lancet 362: 1733-1745, 2003.
2. Trifonov V, Khiabanian H, Greenbaum B and Rabadan R: The origin of the recent swine influenza seasonal influenza A(H1N1) virus infecting humans. Euro Surveill 14: 19193, 2009.
3. Centers for Disease Control and Prevention (CDC): Update: Infections with a Swine-Origin Influenza A (H1N1) Virus, United States and other countries, 2009. http://www.cdc.gov/mmwr.
4. Hayden FG and Hay AJ: Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr Top Microbiol Immunol 176: 119-130, 1992.
5. de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, Bach VC, Phan TQ, Do QH, Guan Y, Peiris JS, Tran TH and Farrar J: Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 353: 2667-2672, 2005.
6. Deyde VM, Xu X, Bright RA, Shaw M, Smith CB, Zhang Y, Shu Y, Gubareva LV, Cox NJ and Klimov AI: Surveillance of resistance to adamantanes among influenza A (H3N2) and A (H1N1) viruses isolated worldwide. J Infect Dis 196: 249-257, 2007.
7. Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y and Kawaoka Y: Avian flu: isolation of drug-resistant H5N1 virus. Nature 437: 1108, 2005.
8. Shetty AK and Peek LA: Peramivir for the treatment of influenza. Expert Rev Anti Infect Ther 10: 123-143, 2012.
9. Chang YS and Ho YL: Studies on the homonymic Chinese crude drug species in Taiwan. Evaluation of the quality of DA-Ching-Yeh and Ching-Dai. Anal Sci 17: a423-a426, 2001.
10. Xu LH, Huang F, Cheng T and Wu J: Antivirus constituents of radix of Isatis indigotica. Chin J Nat Med 3: 359-361, 2005.
11. Li L, Dong TY, Li XL and Qiao CZ: Study of quality control on herbal drugs and preparations of daqingye and banlangen. Acta Pharm Sin 28: 229-233, 1993 (In Chinese).
12. Huang QS, Yoshihiro K and Natori S: Isolation of 2-hydroxy -3-butenyl thiocyanate, epigoitrin and adenosine from 'banlangen', Isatis indigotica root. Planta Med 42: 308-310, 1981.
13. Li X, He LW and Sun DD: The methods of anti-virus extract from Radix and its use. P: CN1969923, 05-30, 2007.
14. Zuo Y, Dai M, Wang ZY and Liu J: Effects of banlangen polysaccharide on mice resistance to Influenza virus infection. WCJ PS 23: 666-667, 2008.
15. An YQ, Jia XB, Yuan HJ, Chen Y and Jin XY: Thinking in studies on antiviral material base of Radix isatidis. Chin Tradit Herbal Drugs 39: 616-619, 2008.
16. Kizu H, Shimana H and Tomimori T: Studies on the constituents of clematis species. VI. The Constituents of Clematis stans Sieb. et Zucc. Chem Pharm Bull 43: 2187-2194, 1995.
17. He LW, LI X, Chen JW, Xia Y and Wang YY: Determination of lariciresinol-4,4'-bis-O-b-D-glucopyranoside from Radix isatidis by HPLC. Chin Tradit Herbal Drugs 39: 1895-1897, 2008.
18. Ehrhardt C, Hrincius ER, Korte V, Mazur I, Droebner K, Poetter A, Dreschers S, Schmolke M, Planz O and Ludwig S: A polyphenol rich plant extract, CYSTUS052, exerts anti-influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance. Antiviral Res 76: 38-47, 2007.
19. Yingsakmongkon S, Miyamoto D, Sriwilaijaroen N, Fujita K, Matsumoto K, Jampangern W, Hiramatsu H, Guo CT, Sawada T, Takahashi T, Hidari K, Suzuki, T, Ito M, Ito Y and Suzuki Y: Invitro inhibition of human influenza A virus infection by fruit-juice concentrate of Japanese plum (Prunus mume SIEB. et ZUCC). Biol Pharm Bull 31: 511-515, 2008.
20. Miyamoto D, Hasegawa S, Sriwilaijaroen N, Yingsakmongkon S, Hiramatsu H, Takahashi T, Hidari K, Guo CT, Sakano Y, Suzuki T and Suzuki Y: Clarithromycin inhibits progeny virus production from human influenza virus-infected host cells. Biol Pharm Bull 31: 217-222, 2008.
21. Knox YM, Suzutani T, Yosida I and Azuma M: Anti-influenza virus activity of crude extract of Ribes nigrum L. Phytother Res 17: 120-122, 2003.
22. Graham BS, Perkins MD, Wright PF and Karzon DT: Primary respiratory syncytial virus infection in mice. J Med Virol 26: 153-162, 1998.
23. Hui MB, Lien EJ and Trousdale MD: Inhibition of human adenoviruses by 1-(2'-hydroxy-5'-methoxybenzylidene) amino-3-hydroxyguanidine tosylate. Antiviral Res 24: 261-273, 1994.
24. Mao H, Thakur CS, Chattopadhyay S, Silverman RH, Gudkov A and Banerjee AK: Inhibition of human parainfluenza virus type 3 infection by novel small molecules. Antiviral Res 77: 83-94, 2008.
25. Ho HY, Cheng ML, Weng SF, Leu YL and Chiu DT: Antiviral effect of epigallocatechin gallate on enterovirus 71. J Agric Food Chem 57: 6140-6147, 2009.
26. Kaiser L, Crump CE and Hayden FG: In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses. Antiviral Res 7: 215-220, 2000.
27. Reed LJ and Muench H: A simple method of estimating fifty percent endpoints. Am J Hyg 27: 493-497, 1938.
28. Ludwig S, Wolff T, Ehrhardt C, Wurzer WJ, Reinhardt J, Planz O and Pleschka S: MEK inhibition impairs influenza B virus propagation without emergence of resistant variants. FEBS Lett 561: 37-43, 2004.
29. Peng JP, Fan GR and Wu YT: Isolation and purification of clemastanin B and indigoticoside A from Radix isatidis by high-speed counter-current chromatography. J Chromatogr A 1091: 89-93, 2005.
30. Taubenberger JK: The origin and virulence of the 1918 'Spanish' influenza virus. Proc Am Philos Soc 150: 86-112, 2006.
31. Mak NK, Leung CY, Wei XY, Shen XL, Wong RN, Leung KN and Fung MC: Inhibition of RANTES expression by indirubin in influenza virus-infected human bronchial epithelial cells. Biochem Pharmacol 67: 167-174, 2004.
32. Yamada H: Antiviral compositions containing new glycoprotein from Isatis tinctoria. Acta Pharm Sin 1160: 599, 1999.
33. Palese P: Influenza: old and new threats. Nat Med 10 (Suppl12): S82-S87, 2004.
34. Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, Rapp UR and Ludwig S: Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat Cell Biol 3: 301-305, 2001.
35. Marjuki H, Alam MI, Ehrhardt C, Wagner R, Planz O, Klenk HD, Ludwig S and Pleschka S: Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Calpha-mediated activation of ERK signaling. J Biol Chem 81: 16707-16715, 2006.
36. Wu MS, Yen HR, Chang CW, Peng TY, Hsieh CF, Chen CJ, Lin TY and Horng JT: Mechanism of action of the suppression of influenza virus replication by Ko-Ken Tang through inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway and viral RNP nuclear export. J Ethnopharmacol 134: 614-623, 2011.
37. Mazur I, Wurzer WJ, Ehrhardt C, Pleschka S, Puthavathana P, Silberzahn T, Wolff T, Planz O and Ludwig S: Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity. Cell Microbiol 9: 1683-1694, 2007.
38. Bright RA, Medina MJ, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, Povinelli L, Cox NJ and Klimov AI: Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 366: 1175-1181, 2005.
39. Bright RA, Shay DK, Shu B, Cox NJ and Klimov AI: Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 295: 891-894, 2006.
40. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB and Uyeki TM: Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-2615, 2009.